Conditional survival in patients treated for gastric cancer with a curative intent
- PMID: 36735183
- DOI: 10.1002/jso.27209
Conditional survival in patients treated for gastric cancer with a curative intent
Abstract
Background and objectives: Conditional survival (CS) provides the probability that a patient who has already survived a certain number of years after treatment will survive an additional number of years. We aim to study the CS of patients with gastric cancer.
Methods: Patients who underwent curative intent treatment for gastric cancer in a single institution between 2007 and 2018 were included in the analysis. The probability (CS) that a patient who has already survived x years will survive an additional y year, was calculated as CS (y/x) = S(x + y)/S(x).
Results: The probability of surviving an additional 3 years if a patient had already survived 1, 2, 3, 4, and 5 years after treatment were 64.2%, 74.5%, 81.6%, 83.2%, and 88.2%, respectively whereas the 4-, 5-, 6-, 7-, and 8-year actuarial OS were only 47.2%, 43.2%, 41%, 39.4%, and 38.2%, respectively. The independent prognostic factors associated with poor survival were age >60 years, T stage ≥T3, N stage ≥N2, proximal tumor location, and lymph node ratio > 0.18. Patients with these high-risk features showed the greatest increase in CS3 over time.
Conclusion: CS estimates provided a more dynamic prognostic information over time for patients treated for gastric cancer with curative intent.
Keywords: conditional survival; gastric cancer; lymph node ratio; surgery; survival.
© 2023 Wiley Periodicals LLC.
References
REFERENCES
-
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. Published online February 4, 2021.
-
- Report of National Cancer Registry Programme (2012-2016); National Cancer registry Programme (ICMR-NCDIR), Bangalore, India, 2020.
-
- Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). The Lancet. 2015;385:977-1010.
-
- Dickman PW, Adami H-O. Interpreting trends in cancer patient survival. J Intern Med. 2006;260:103-117.
-
- Kaplowitz SA, Campo S, Chiu WT. Cancer patients' desires for communication of prognosis information. Health Commun. 2002;14:221-241.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical